These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6636310

  • 1. [Kinetics of the inhibition of succinate dehydrogenase in bull adrenal cortex by malonate and oxaloacetate].
    Mandrik KA, Vonsovich VA, Vinogradov VV.
    Ukr Biokhim Zh (1978); 1983; 55(5):503-6. PubMed ID: 6636310
    [Abstract] [Full Text] [Related]

  • 2. [Interaction of succinate dehydrogenase with succinate and oxaloacetate during enzyme activation-deactivation].
    Vinogradov VV, Mandrik KA, Vonsovich VA.
    Ukr Biokhim Zh (1978); 1986; 58(2):16-9. PubMed ID: 3705198
    [Abstract] [Full Text] [Related]

  • 3. [Interaction of succinate dehydrogenase and oxaloacetate].
    Kotliar AB, Vinogradov AD.
    Biokhimiia; 1984 Apr; 49(4):667-75. PubMed ID: 6733163
    [Abstract] [Full Text] [Related]

  • 4. Localization of the oxaloacetate-binding site in the iron-flavoprotein subunit of the inhibitor-succinate dehydrogenase complex.
    Winter DB, King TE.
    Biochem Biophys Res Commun; 1974 Jan 23; 56(2):290-5. PubMed ID: 4823868
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of mitochondrial succinate dehydrogenase by substrate type activators.
    Gutman M.
    Biochemistry; 1977 Jul 12; 16(14):3067-72. PubMed ID: 889791
    [No Abstract] [Full Text] [Related]

  • 10. [Mechanism of succinate dehydrogenase inhibition by oxaloacetate].
    Vinogradov AD, Zimakova NI, Solntseva TI.
    Dokl Akad Nauk SSSR; 1971 Nov 11; 201(2):359-62. PubMed ID: 5131105
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade.
    Zeevalk GD, Derr-Yellin E, Nicklas WJ.
    J Pharmacol Exp Ther; 1995 Dec 11; 275(3):1124-30. PubMed ID: 8531072
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The steady state activity of succinate dehydrogenase in the presence of opposing effectors.II. Reductive activation of succinate dehydrogenase in presence of oxaloacetate.
    Gutman M, Silman N.
    Mol Cell Biochem; 1975 Jun 30; 7(3):177-85. PubMed ID: 239334
    [Abstract] [Full Text] [Related]

  • 17. [Dissociation constants of succinate dehydrogenase complexes with succinate, fumarate and malonate].
    Kotliar AB, Vinogradov AD.
    Biokhimiia; 1984 Mar 30; 49(3):511-8. PubMed ID: 6722218
    [Abstract] [Full Text] [Related]

  • 18. Intrastriatal injections of the succinate dehydrogenase inhibitor, malonate, cause a rise in extracellular amino acids that is blocked by MK-801.
    Messam CA, Greene JG, Greenamyre JT, Robinson MB.
    Brain Res; 1995 Jul 03; 684(2):221-4. PubMed ID: 7583227
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.